Clinical Pharmacokinetics of Apto-253 Support Its Use As a Novel Agent for the Treatment of Relapsed or Refractory Hematologic Malignancies

Autor: Rice, William G., Lightfoot, Jeff *, Zhang, Hongying *, Cheng, Tiffany *, Vellanki, Avanish *, Peralta, Robert *, Howell, Stephen B *, Local, Andrea *, Chau, Fannie *, Esquivies, Luis *
Zdroj: In Blood 3 December 2015 126(23):4934-4934
Databáze: ScienceDirect